ScreenerHero

BMX BioMaxima S.A.

GPW · PL · Healthcare · Diagnostics & Research · biomaxima.com
9.900PLN-0.40%Mkt Cap: 10.51M $P/E: —

BioMaxima S.A. produces and distributes microbiological media, reagents, and in vitro diagnostic equipment in Poland. It offers microbiology products, including ready to use media, such as plates, bottles, bags, and medi…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$250.23BUSDP/E 36.4
DHR
Danaher Corporation
$155.51BUSDP/E 39.4
NTRA
Natera, Inc.
$61.35BUSD
LONN
Lonza Group AG
$45.82BUSDP/E 38.1
A
Agilent Technologies, Inc.
$48.29BUSDP/E 33.8
ILMN
Illumina, Inc.
$44.35BUSDP/E 54.8
IQV
IQVIA Holdings Inc.
$43.80BUSDP/E 33.1
WAT
Waters Corporation
$43.21BUSDP/E 111.4
IDXX
IDEXX Laboratories, Inc.
$41.58BUSDP/E 37.0
MTD
Mettler-Toledo International Inc.
$30.89BUSDP/E 34.7
DGX
Quest Diagnostics Incorporated
$25.63BUSDP/E 24.7
GH
Guardant Health, Inc.
$25.12BUSD
LH
Labcorp Holdings Inc.
$25.03BUSDP/E 25.5
RVTY
Revvity, Inc.
$17.56BUSDP/E 75.3
MEDP
Medpace Holdings, Inc.
$17.32BUSDP/E 36.4
CRL
Charles River Laboratories International, Inc.
$14.84BUSD
ERF
Eurofins Scientific SE
$14.05BUSDP/E 26.2
ICLR
ICON Public Limited Company
$12.99BUSDP/E 177.2
BIM
bioMérieux S.A.
$10.02BUSDP/E 20.0
QGEN
Qiagen N.V.
$9.46BUSDP/E 23.2

Key Statistics

Company
Market Cap10.51M USD
Enterprise Value14.53M USD
Revenue (TTM)15.13M USD
Gross Profit6.75M USD
Net Income (TTM)26.59K USD
Revenue/Share14.25 PLN
Last Price9.900 PLN
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees143
CountryPL
SectorHealthcare
IndustryDiagnostics & Research
ISINPLBIOMX00015
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA15.61
EV/Revenue0.96
P/S0.70
P/B0.87
EPS (TTM)-0.02
EPS (Forward)—
52W Range
9.21013% of range14.50
52W High14.50 PLN
52W Low9.210 PLN
Profitability
Gross Margin43.76%
Oper. Margin3.87%
EBITDA Margin6.15%
Profit Margin0.17%
ROE0.22%
ROA0.14%
Growth
Revenue Growth-7.60%
Earnings Growth-44.10%
Cash Flow & Leverage
Operating CF854.50K USD
CapEx (TTM)253.01K USD
FCF Margin4.32%
FCF Yield6.22%
Net Debt3.98M USD
Net Debt/EBITDA4.27
Balance Sheet
Debt/Equity0.30
Current Ratio1.39
Quick Ratio0.66
Book Value/Sh11.47 PLN
Cash/Share0.10 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJun 16, 2023
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.19M
Float3.77M
Insiders34.41%
Institutions0.05%
Technical
SMA 5010.09 (-1.9%)
SMA 20011.04 (-10.3%)
Beta0.31
S&P 52W Chg14.58%
Avg Vol (30d)2.36K
Avg Vol (10d)2.99K
Technical Indicators
RSI (14)37.5
MACD-0.0431
MACD Signal-0.0189
MACD Hist.-0.0241
BB Upper10.29 PLN
BB Middle10.07 PLN
BB Lower9.859 PLN
BB Width4.24%
ATR (14)0.1255 PLN
Vol Ratio (20d)1.00x